Unproven stroke treatment is no more effective than placebo, clinical trial finds

The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, “perispinal” etanercept—injected into the spinal area—is no more effective than an inactive dummy drug, or placebo.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup